Dedicated Efforts Are Paying Off in Immunotherapy

Mike Hennessy
Published: Monday, May 01, 2017
Mike Hennessy

OncLive Chairman,
Mike Hennessy

In recent years, immunotherapy advancements have generated much excitement in oncology, and that is no different in the urologic arena. We have been reporting on these developments as they come up, and so far, we have seen progress this year for understanding, developing, and gaining regulatory approval for immunotherapies in urologic cancers.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Community Practice Connections™: How Do We Leverage PARP Inhibition Strategies in the Contemporary Treatment of Breast Cancer?May 31, 20191.5
Publication Bottom Border
Border Publication